resistance to targeted therapies and the importance of retesting davies
Published 6 years ago • 187 plays • Length 5:22Download video MP4
Download video MP3
Similar videos
-
1:45
gracecastuc-034_lung_management strategies for acquired resistance to targeted therapies
-
26:54
what is acquired resistance to targeted therapy, and why does it occur?
-
6:04
resistance on targeted therapy: questions patients should ask-targeted therapies in lung cancer 2023
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
4:16
how targeted therapies treat cancer davies
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
12:13
managing immunotherapy side effects - part 2
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
7:49
alk nsclc treatment options - 2022 program: targeted therapies forum
-
4:57
adding to targeted therapy: current statistics and biology - targeted therapies in lung cancer 2023
-
4:04
challenges of targeted kras treatment & current treatments - targeted therapies in lung cancer 2023
-
22:49
grace targeted therapies lung cancer 2021 - management of uncommon egfr mutations including exon 20
-
0:39
slcvl - hunis - #11 acquired resistance to targeted therapies
-
2:11
emerging therapies in alk nsclc - 2022 program: targeted therapies forum
-
2:26
gracecastuc-061_lung_dr. sandler: my approach to acquired resistance for targeted therapies in lc
-
5:51
how do we approach acquired resistance to targeted therapies in lung cancer?
-
8:46
grace targeted therapies in lung cancer 2021 - liquid and tissue biopsies in acquired resistance
-
4:35
the importance of biomarker testing: what is liquid biopsy? - targeted therapies in lung cancer 2023
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
14:41
handling the stress of scans - 2022 program: targeted therapies forum
-
6:03
barriers to biomarker testing: ordering tests - targeted therapies in lung cancer 2023
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023